Adrenal chromaffin cells and sympathetic neurons are related, but phenotypically distinct derivatives of the neural crest. Molecular cues that determine the chromaffin cell phenotype have not yet been identified; in contrast to a widely held belief, glucocorticoid signaling is apparently not relevant (Development 126 (1999(Development 126 ( ) 2935. Transforming growth factor-bs (TGF-bs) regulate various aspects of embryonic development and are expressed in the environment of sympathoadrenal (SA) progenitor cells. We have previously shown that neutralization of endogenous TGF-b from E4 to E8 in the quail embryo significantly increases numbers of adrenal tyrosine hydroxylase-positive cells. Whether endogenous TGF-b may also be involved in influencing phenotypic development of adrenal chromaffin cells and their SA progenitors has not been analyzed. We now demonstrate that neutralization of endogenous TGF-b1, -b2 and -b3 with a pan-anti-TGF-b antibody in quail embryos during distinct time windows does not alter phenotypic development of chromaffin cells. In situ hybridizations revealed unaltered expression of neurofilament (NF-160), synaptotagmin I and neurexin I in adrenal glands. Likewise, the NF-associated antigen 3A10, and polyphosphorylated NF epitopes (RT 97) were unaltered. Most importantly, the typical ultrastructure of adrenal chromaffin cells including their large chromaffin secretory granules, a hallmark of the neuroendocrine phenotype, which distinguishes them from sympathetic neurons, was not affected. We therefore conclude that neutralization of endogenous TGF-b influences chromaffin cell proliferation, but does not interfere with the development of the typical chromaffin cell phenotype. q
Introduction
Transforming growth factor-bs (TGF-bs) constitute a superfamily of multifunctional cytokines with important roles in embryonic development, differentiation, and cell cycle control (Böttner et al., 2000; Unsicker and Strelau, 2000; Dünker and Krieglstein, 2000 , for reviews). Actions of TGF-bs crucially depend on the cell type and cellular contexts, making TGF-bs probably the most versatile family of growth factors (Roberts and Sporn, 1990) . Three TGF-b isoforms are known in mammals, and their expression patterns are distinct, but widely overlapping. Each isoform seems to have specific roles in the in vivo setting. This fact is reflected by the non-overlapping phenotypes of mutant mice deficient for the TGF-b1, -b2 or -b3 genes, respectively , for a review).
The phenotypical defects are mainly found in non-neuronal tissues, possibly suggesting that TGF-b2 and -b3, which are consistently co-expressed in the nervous system Unsicker et al., 1991) , may compensate for each other.
We have previously introduced a method to 'conditionally knock out' all three TGF-b isoforms in chick and quail embryos by immunoneutralization with an anti-pan-TGF-b antibody recognizing all three TGF-b isoforms Combs et al., 2000) . We have exploited this method for studying the effects of endogenous TGF-bs in ontogenetic and lesion-induced neuron death, and to validate in vitro data (Wolf et al., 1999 ) that had indicated a role of TGF-bs in the control of chromaffin cell proliferation.
Adrenal chromaffin cells are progeny of the neural crest. The neural crest cells destined to become sympathoadrenal (SA) progenitors delaminate from the neural tube under the influence of BMP-4, and migrate ventrally through the rostral somites into the area of the dorsal aorta (Le Douarin and Kalcheim, 1999) . In this location, SA cells are instructed to a catecholaminergic fate by BMP-2, -4, and -7 synthesized by the dorsal aorta (Reissmann et al., 1996; Shah et al., 1996) . TGF-b2 and -b3 isoforms are coexpressed in somites, the notochord, and wall of the dorsal aorta (Unsicker et al., 1996) . Thus, migrating SA cells pass and reside close to sources of TGF-b2 and -b3. TGF-b2 and -b3 are also expressed in chromaffin cells after their migration into the adrenal gland (Combs et al., 2000) , and secretion of TGF-b from chromaffin cells is well-established (Krieglstein and Unsicker, 1995) .
Both chromaffin cells and sympathetic neurons are progeny of the neural crest, but phenotypically, and in regard to proliferation, different (Seidl and Unsicker, 1989a,b; Unsicker et al., 1989; Anderson, 1993; Unsicker, 1993) . Sympathetic neurons enter a post-mitotic stage, whereas chromaffin cells retain a lifelong potential for mitosis. The exact differential cues determining neuronal or neuroendocrine fate have not yet been discovered. The tissues lining the migration pathway of the neural crest cells to the sites of the formation of the primary sympathetic strands at the dorsal aorta and their further migration into definitive sympathetic ganglia and the adrenal gland are considered to be important for the induction of the sympathetic neuronal or chromaffin cell phenotype, respectively (Anderson, 1993; Unsicker, 1993; Groves and Anderson, 1996) . In this setting, adrenal glucocorticoids were thought to be essential in forming the chromaffin cell phenotype, but recent analysis of the glucocorticoid receptor (GR) knockout mouse has proven glucocorticoid signaling not crucial to the neuron-chromaffin cell decision (Finotto et al., 1999) . Given the prominent expression of TGF-b2 and -b3 along the migratory route and in the final location of chromaffin progenitor cells (see above), we have asked whether endogenous TGF-bs might be implicated in the neuron-neuroendocrine cell decision. By neutralizing TGF-b1, -b2, and -b3 during various time windows of chromaffin cell development in quail embryos, we found no evidence for a putative role of TGF-b in the initial instructive and later differentiative processes that generate mature chromaffin cells.
Results
In quail embryos, neural crest cells that have started to delaminate from the dorsal neural tube at E2 arrive at the dorsal aorta at E4, where they form the primary sympathetic ganglia and start to express catecholaminergic and neuronal markers (Vogel and Weston, 1990) .
These SA cells subsequently migrate dorsolaterally to form secondary sympathetic ganglia, or ventrally to invade the adrenal anlagen (Vogel and Weston, 1990) . At E8, the adrenal gland is homogeneously populated with tyrosine hydroxylase (TH)-positive cells. To analyze a potential role of TGF-b in SA cell invasion of the adrenal anlagen and putative suppression of neuronal markers in the adrenal environment, quail embryos were treated from E4 to E8 with pan-TGF-b antibodies as described in Section 4. In situ hybridizations on E8 embryos revealed signals for neurofilament 160 mRNA in adrenal SA cells both inside the gland and at its surface (Fig. 1) . Messenger RNA for neurexin I, an important constituent of the neurosecretory release machinery, was prominent in SA cells located at the surface, but not in the center of the gland. Both, the neuro- Fig. 1 . In situ hybridizations showing neurofilament 160, synaptotagmin I and neurexin I mRNAs in E8 quail adrenal gland. Both markers for chromaffin cells are approximately equally intense. However, neurexin I mRNA is more pronounced in chromaffin cells located at the periphery of the gland. Treatment with pan-anti-TGF-b antibodies from E4 to E8 does not affect expression levels of either mRNA. In situ hybridization showing TH is shown as a control and more prominent in treated quails in accordance with our previous data (Combs et al., 2000) . As a control, the corresponding TH sense hybridization is shown. Scale bar, 200 mm. filament 160 and the neurexin I signals, were identically distributed and equally strong in TGF-b antibody-treated and in control embryos. These data indicate that adrenal chromaffin cells in the E8 quail embryo express neurofilament 160, synaptotagmin I and neurexin I, and that expression levels and distribution patterns of the mRNAs are not affected by neutralization of endogenous TGF-b1, -b2 andb3 (Fig. 1) .
Next, we investigated the phenotype of adrenal chromaffin cells in E15 embryos that had been treated daily from E4 with pan-TGF-b-antibodies. At this age, chromaffin cells weakly expressed neurofilament 160 mRNA (Fig. 2) . Antibodies recognizing polyphosphorylated neurofilament epitopes (RT 97; Wood and Anderton, 1981; Anderton et al., 1982; Walro et al., 1997) , and the neurofilament-associated antigen 3A10 (Serafini et al., 1996) revealed strands of peri-and intra-adrenal nerve fibers, but no staining of chromaffin cells (not shown). Neurexin I and synaptotagmin I mRNAs were weakly expressed and unaltered by the TGFb antibody treatments (Fig. 2) . The specific ultrastructure of chromaffin cells with their large chromaffin granules is probably the most reliable marker for the neuroendocrine phenotype of SA cells. Fig. 3 shows electron micrographs of TGF-b antibody-treated and control embryos. Apparently, neutralization of endogenous TGF-b did not overtly affect the ultrastructure of adrenal chromaffin cells. In particular, chromaffin granules appeared to be unaltered in terms of shapes, sizes and electron density. Synaptic terminals on chromaffin cells were normal, too. Together, these data suggest that adrenal chromaffin cells develop normally following neutralization of endogenous TGF-b1, -b2 and -b3 isoforms.
Discussion
The above data are pertinent to the still unresolved issue of which factors influence the development of SA progenitors cells into neuroendocrine chromaffin cells. Previous in vitro studies using isolated SA progenitor cells or immature chromaffin cells had led to the hypothesis that glucocorticoid signaling is essential for suppressing neuronal traits and promoting endocrine characteristics, including adrenaline synthesis in developing chromaffin cells (Unsicker et al., 1978; Doupe et al., 1985a,b; Anderson and Axel, 1986; Anderson and Michelson, 1989; Seidl and Unsicker, 1989a,b; Michelson and Anderson, 1992) . These effects of glucocorticoids had been shown to be mediated through the GR (Michelson and Anderson, 1992) . Analysis of mice lacking a functional GR had failed to reveal a phenotype of adrenal SA cells, contradicting this hypothesis. GR null/ null mutants had adrenal chromaffin cells that, in terms of number and most markers, including ultrastructure, were undistinguishable from their wildtype counterparts (Finotto et al., 1999) . However, GR null/null chromaffin cells did not express the adrenaline synthesizing enzyme PNMT, i.e. they did not synthesize adrenaline. This was an expected result, since PNMT activity has long been known to crucially require glucocorticoid stimulation (Wurtman and Axelrod, 1965; Wurtman et al., 1968) . In search of alternative signals that might induce neuroendocrine as opposed to neuronal features in SA progenitor cells, we investigate a putative role of TGF-b in this developmental process. TGF-b2 and -b3 have been shown to localize to the environment encountered by migrating neural crest and SA progenitor cells (Unsicker et al., 1996) . Members of the TGF-b superfamily are known to play important roles in lineage decisions of neural crest cells. BMP-4, -2 and -7 induce catecholaminergic and neuronal markers in crest cells (Reissmann et al., 1996; Shah et al., 1996; Varley et al., 1995) . Moreover, TGF-b itself has been shown to promote adrenergic traits in cultured neural crest cells (Howard and Gershon, 1993; Zhang et al., 1997) . Similarly, glial cell line-derived neurotrophic factor (GDNF), a member of a distant subfamily of TGF-bs , has been described to induce a dramatic increase in TH-immunoreactive cells in mammalian crest cell cultures (Maxwell et al., 1996) . In the latter paradigm, however, TGF-b failed to increase numbers of TH-positive cells, suggesting that a role of TGF-b in the induction of adrenergic neuronal or chromaffin traits is still inconclusive. BMPs, distinct members of the TGF-b superfamily, have been shown to be essential in vivo for sympathetic neuron development and establishment of Cash-1 and Phox2 genes in this lineage (Schneider et al., 1999) Gene disruption technology permits to challenge hypotheses based on in vitro data in an in vivo setting and to analyze the physiological relevance of a molecule. As for now, there are only single gene knockouts concerning TGFbs, TGF-b1, TGF-b2 and TGF-b3 . All three mutant mice reveal lethal phenotypical alterations that are largely non-overlapping (Dickson et al., 1995; Sanford et al., 1997) . So far, they have failed to reveal phenotypes in the nervous system, including sympathetic neurons and chromaffin cells, possibly because of the consistent co-expression of TGF-b2 and TGF-b3 in the developing and adult nervous system Unsicker et al., 1991) and putative compensatory effects. The knockout of the TbRII receptor, which would theoretically be helpful to reveal the effect of a complete loss in signaling by TGF-b1, -b2 and -b3, is lethal at E10.5 (Masanobu et al., 1996) . Therefore, at least a double knockout of TGF-b2 and -b3 or a conditional knockout of their cognate receptors TbRI or II would be necessary to evaluate a putative role of TGF-b signaling in SA progenitor cell development and phenotypic decisions. By neutralizing endogenous TGF-b1, -b2 and -b3 in the quail embryo using pan-anti-TGF-b antibodies during distinct time windows, we have generated 'conditional knockouts' that have helped to elucidate effects of TGF-b in the development of the chromaffin phenotype.
Immunoneutralization of TGF-b1, -b2 and -b3 has been successfully employed to unravel the roles of TGF-b in the regulation of ontogenetic and lesion-induced neuron survival and death . Also, reduction of TGF-b has been shown to increase proliferation of chromaffin cells in vivo (Combs et al., 2000) . In these studies, we had determined amounts of endogenous TGF-b (by using the mink lung epithelial cell assay; Abe et al., 1994) and established appropriate doses of antibodies to neutralize endogenous TGF-bs (Combs et al., 2000; . Based on these previous experiments, we used 5 mg of the TGF-b antibody, which neutralized 5 ng of each available recombinant TGF-b, including chicken TGF-b3 (to .98%) and TGF-b in homogenates from E9 chick embryos (to .95%) as assessed in a bioassay using mink lung epithelial cells (Fig. 1a in Krieglstein et al., 2000) .
The present analysis of quails treated with the neutralizing TGF-b antibody shows that a substantial reduction of endogenous TGF-bs during selected time frames does not alter the chromaffin cell phenotype. Treatment with equal amounts of anti-TGF-b had altered chromaffin cell proliferation (Combs et al., 2000) and must therefore have had neutralizing effects in the adrenal gland. Previous studies had established that rhodaminelabeled IgG applied to the chorionic-allantoic membrane could be detected throughout the whole embryo.
The phenotypical cornerstones which we analyzed were various neuronal markers and ultrastructural features; the latter are still the most reliable means of identifying chromaffin cells. Neurofilament is a classical characteristic of neurons. At E8, SA cells have migrated into the adrenal gland and express neurofilament 160 mRNA. At E15, a minor subpopulation of adrenal cells located in the periphery of the gland, is strongly positive for neurofilament 160, whereas the great majority of chromaffin cells express only very low levels of neurofilament 160 mRNA. Neurofilament immunostaining was less conclusive, since not only chromaffin cells, but also the abundant preganglionic nerve fibers were stained. Synaptotagmin I and neurexin I, key molecules of the neuronal secretory release machinery, were distinctly expressed in the E8 adrenal gland, with higher levels of expression being seen in peripherally located chromaffin cells, and lower levels in centrally located cells. At E15, both synaptotamin and neurexin mRNAs were homogeneously weakly expressed, except for a very small subpopulation located in the periphery of the adrenal gland. Thus, neurofilament 160, synaptotagmin I and neurexin I are clearly down-regulated during normal development of avian adrenal chromaffin cells, with the exception of a small subpopulation of peripherally located cells, which are known to represent a neuronal phenotype (Unsicker, 1973) . Consistently, TGF-b is not involved in a physiological reduction of neuronal markers in developing chromaffin cells.
The characteristic ultrastructure of chromaffin cells with its large chromaffin granules is still the hallmark of the chromaffin cell phenotype. Consistent with the above data, chromaffin cells treated with TGF-b antibodies displayed the typical ultrastructural features.
In conclusion, the present study provides evidence that the TGF-b isoforms -b1, -b2 and -b3 are not crucially involved in the generation of the neuroendocrine phenotype of SA cells.
Experimental procedures

Antibody treatment of quail embryos
Quail embryos were treated with a neutralizing antibody recognizing all three TGF-b isoforms ('pan-TGF-b antibody'; R&D Systems, Minneapolis, MN, USA). The quail eggs were pre-incubated at 378C until the desired age. Five micrograms of anti-TGF-b-1, -2, -3, diluted in 50 ml phosphate-buffered saline (PBS) enriched with 100 ml/ml penicillin, 100 mg/ml streptomycin and 200 mg/ml neomycin (PSN), were administered to the chorioallantoic membrane through a small window in the egg shell (Oppenheim et al., 1993; Krieglstein et al., 2000) . Antibody was added every day for specific time frames. Control specimens were treated with PBS and PSN only or by replacement of TGF-b by a monoclonal IgG coupled with TRITC (Sigma, Deisenhofen) as described by Krieglstein et al. (2000) . A series of necessary control experiments has recently been carried out . First, the specificity of the antibody was determined by dot blot, providing evidence that the antibody specifically recognized TGF-b1, -b2, and -b3, but none of the other ten members of the TGF-b superfamily and 34 non-TGF-b cytokines tested. Five micrograms of this antibody neutralized 5 ng of each available recombinant TGF-b, including chicken TGF-b3 (to .98%) and TGF-b in homogenates from E9 chick embryos (to .95%) as assessed in a bioassay using mink lung epithelial cells (Fig. 1a in Krieglstein et al., 2000) . Five micrograms of the antibody were also sufficient to neutralize the total amount of TGF-bs in quail embryos to an extent better than 98% (Combs et al., 2000) . A corresponding control IgG conjugated to rhodamine was employed to demonstrate penetration of the antibody throughout the whole embryo.
Staging, fixation, and sectioning of embryos
Quail embryos were killed on days E4.5, E8 and E15, respectively, by decapitation. For in situ hybridizations and immunohistochemistry, the embryos at ages E4.5 and E8 were fixed in toto in freshly made, ice-cold 4% paraformaldehyde (PFA) in phosphate buffer (pH 7.6) at 48C overnight, then washed in PBS, and transferred into 15% sucrose for 24 h at 48C. All specimens were then mounted in Tissue Tek (Miles, Elkhart, IN) on dry ice and stored until further processing at 2708C. E15 quail embryos were fixed after removal of the skin, limbs, heart, lungs, and gastrointestinal tract as described above. Cryosections were cut at 15 mm in a Frigocut E (Reichert-Jung, Germany) and placed on gelatin coated slides, kept at 378C for 1 h, and stored at 2708C. Serial sections were cut in the region of the adrenal gland (E8; E15). For electron microscopy, E15 quails were perfused transcardially with phosphate-buffered 4% PFA.
In situ hybridization
4.3.1. Label synthesis cDNAs were available for neurofilament 160 (Zopf et al., 1987) , neurexin I (Patzke and Ernsberger, 2000) and synaptotagmin I (Campagna et al., 1997) . RNA probes for neurofilament 160 (NF-160), synaptotagmin I, and neurexin I were obtained by linearizing the respective plasmids with restriction enzymes (Roche, Mannheim, Germany) and transcribing with the appropriate RNA polymerases (Pharmacia, Freiburg, Germany). Eco R1 and T7 were used for NF-160 and neurexin I, Xho1 and Sp6 for synaptotagmin I. Labeling was performed with the DIG-RNA-labeling kit (Boehringer/ Roche, Mannheim, Germany) and purified with Quick-spincolumns (Boehringer/Roche, Mannheim, Germany), essentially as described by Ernsberger et al. (1997) .
Hybridization
After denaturation of the probe for 10 min at 708C in hybridization buffer, 100 ml of hybridization mix was added/slide under coverslips and incubated over night at 658C. The coverslips were then removed, the sections washed and incubated for 1 h at room temperature with 20% chick serum as a blocking solution. Afterwards, the anti-DIG-antibody (Boehringer/Roche, Mannheim, Germany) was added, the slides were covered with coverslips and incubated overnight at room temperature.
On day 3, slides were washed and incubated with NBT/ BCIP (Boehringer/Roche, Mannheim, Germany) under coverslips, and kept in a dark place at room temperature overnight for the color reaction. On the last day, slides were washed and coverslips were mounted on Kayser's Glycerine-Gelatine (Merck, Germany).
For all used labels, the corresponding sense probes were tested and showed no signals.
Immunohistochemistry
For monitoring the expression of various neuronal markers, we used antibodies recognizing the synaptic vesicle antigen (SV2), polyphosophorylated neurofilament epitopes (RT 97), and a neurofilament-associated antigen (3A10; all from Developmental Hybridoma Bank, University of Iowa, Iowa City, IA). Tissue sections were defrosted and washed in PBS. A blocking solution containing 10% horse serum (HS) in PBS was then added to the sections for 1 h; slides were incubated with the antibodies, diluted at 1:100 in PBS, overnight at 48C, followed by a biotinylated monoclonal secondary antibody and streptavidin-coupled cy3. Coverslips were mounted on Fluorsave mounting medium (Sigma, Deisenhofen, Germany).
Electron microscopy
The dissected adrenal glands were postfixed in a mixture of 1.5% glutaraldehyde and 1.5% PFA in phosphate buffer (pH 7.3) for 48 h, and then fixed in 1% OsO 4 /1.5% potassium hexacyanoferrat, rinsed in 0.1 M cacodylate buffer and 0.2 M sodium maleate buffer (pH 6.0), block-stained with 1% uranyl acetate, and embedded in Epon. Semi-thin sections (1 mm) were stained with toluidine blue. Ultrathin sections (50 nm) were examined with a Zeiss EM10.
